These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9734593)

  • 21. Analgesic use and the risk for progression of chronic kidney disease.
    Kuo HW; Tsai SS; Tiao MM; Liu YC; Lee IM; Yang CY
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):745-51. PubMed ID: 20582905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic nephropathy.
    Gault MH; Barrett BJ
    Am J Kidney Dis; 1998 Sep; 32(3):351-60. PubMed ID: 9740150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal parenchymal disease related to over-the-counter analgesic use.
    Derby LE; Jick H
    Pharmacotherapy; 1991; 11(6):467-71. PubMed ID: 1771146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the sale of analgesic mixtures and non-steroidal anti-inflammatory agents (NSAIDs) continue to be allowed as over-the-counter (OTC) medications?
    Lindeman RD
    Geriatr Nephrol Urol; 1999; 9(1):3-4. PubMed ID: 10435220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence.
    Barrett BJ
    Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S14-9. PubMed ID: 8669423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regular analgesic intake and the risk of end-stage renal failure.
    Pommer W; Bronder E; Greiser E; Helmert U; Jesdinsky HJ; Klimpel A; Borner K; Molzahn M
    Am J Nephrol; 1989; 9(5):403-12. PubMed ID: 2801788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic nephropathy: an underestimated cause of end-stage renal disease.
    Drukker W; Schwarz A; Vanherweghem JL
    Int J Artif Organs; 1986 Jul; 9(4):219-46. PubMed ID: 3536758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary].
    Pintér I; Mátyus J; Czégány Z; Harsányi J; Homoki M; Kassai M; Kiss E; Kiss I; Ladányi E; Lócsey L; Major L; Misz M; Nagy L; Polner K; Rédl J; Solt I; Tichy B; Török M; Varga G; Wagner G; Wórum I; Zsoldos B; Pótó L; Wittmann I; Nagy J
    Orv Hetil; 2001 May; 142(19):1001-5. PubMed ID: 11419294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In memoriam 'analgesic nephropathy' (circa 1972-2006).
    Michielsen P
    Nephrol Dial Transplant; 2007 Apr; 22(4):999-1001. PubMed ID: 17213226
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy.
    Feinstein AR; Heinemann LA; Curhan GC; Delzell E; Deschepper PJ; Fox JM; Graf H; Luft FC; Michielsen P; Mihatsch MJ; Suissa S; Van Der Woude F; Willich S
    Kidney Int; 2000 Dec; 58(6):2259-64. PubMed ID: 11115060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of analgesics and risk of renal cell cancer.
    Chow WH; McLaughlin JK; Linet MS; Niwa S; Mandel JS
    Int J Cancer; 1994 Nov; 59(4):467-70. PubMed ID: 7960214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case-control study on analgesics and nephropathy (SAN): protocol.
    Heinemann LA; Garbe E; Lewis M; van der Woude F; Graf H
    BMC Nephrol; 2005 Aug; 6():9. PubMed ID: 16086834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic study of regular analgesic use and end-stage renal disease.
    Murray TG; Stolley PD; Anthony JC; Schinnar R; Hepler-Smith E; Jeffreys JL
    Arch Intern Med; 1983 Sep; 143(9):1687-93. PubMed ID: 6615090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesic nephropathy. Clinical course after withdrawal of phenacetin.
    Bell D; Kerr DN; Swinney J; Yeates WK
    Br Med J; 1969 Aug; 3(5667):378-82. PubMed ID: 5797777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic nephropathy and the use of nonsteroidal anti-inflammatory drugs in renal patients: new insight.
    Bennett WM; Porter GA
    J Nephrol; 1998; 11(2):70-5. PubMed ID: 9589376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analgesic nephropathy].
    Pintér I; Nagy J
    Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Declining incidence of analgesic nephropathy in Canada.
    Wilson DR; Gault MH
    Can Med Assoc J; 1982 Sep; 127(6):500-2. PubMed ID: 7116267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diagnosis of analgesic nephropathy].
    Thieler H; Schäfer W
    Z Gesamte Inn Med; 1988 Sep; 43(17):499-504. PubMed ID: 3239117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.